| PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ... Genes 11 (7), 719, 2020 | 92 | 2020 |
| HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer K Venetis, E Crimini, E Sajjadi, C Corti, E Guerini-Rocco, G Viale, ... Frontiers in molecular biosciences 9, 834651, 2022 | 79 | 2022 |
| Targeting immune-related biological processes in solid tumors: we do need biomarkers F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ... International journal of molecular sciences 20 (21), 5452, 2019 | 57 | 2019 |
| Impact of rehabilitation on breast cancer related fatigue: a pilot study M Invernizzi, A De Sire, L Lippi, K Venetis, E Sajjadi, F Gimigliano, ... Frontiers in Oncology 10, 556718, 2020 | 55 | 2020 |
| Breast cancer with bone metastasis: molecular insights and clinical management K Venetis, R Piciotti, E Sajjadi, M Invernizzi, S Morganti, C Criscitiello, ... Cells 10 (6), 1377, 2021 | 42 | 2021 |
| CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress C Corti, K Venetis, E Sajjadi, L Zattoni, G Curigliano, N Fusco Expert Opinion on Investigational Drugs 31 (6), 593-605, 2022 | 38 | 2022 |
| Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients N Fusco, V Vaira, I Righi, E Sajjadi, K Venetis, G Lopez, M Cattaneo, ... Lung Cancer 150, 53-61, 2020 | 38 | 2020 |
| PTEN expression as a complementary biomarker for mismatch repair testing in breast cancer G Lopez, M Noale, C Corti, G Gaudioso, E Sajjadi, K Venetis, D Gambini, ... International Journal of Molecular Sciences 21 (4), 1461, 2020 | 33 | 2020 |
| Biomarkers for precision immunotherapy in the metastatic setting: hope or reality? E Sajjadi, K Venetis, C Scatena, N Fusco Ecancermedicalscience 14, 2020 | 33 | 2020 |
| Cellular immunotherapy in breast cancer: The quest for consistent biomarkers K Venetis, M Invernizzi, E Sajjadi, G Curigliano, N Fusco Cancer treatment reviews 90, 102089, 2020 | 32 | 2020 |
| Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization E Sajjadi, K Venetis, R Piciotti, M Invernizzi, E Guerini-Rocco, ... Cancer Cell International 21, 1-10, 2021 | 30 | 2021 |
| Immunotherapy in breast cancer patients: a focus on the use of the currently available biomarkers in oncology C Criscitiello, E Guerini-Rocco, G Viale, C Fumagalli, E Sajjadi, K Venetis, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 29 | 2022 |
| Quality of life interventions in breast cancer survivors: State of the art in targeted rehabilitation strategies M Invernizzi, A De Sire, K Venetis, E Cigna, S Carda, M Borg, C Cisari, ... Anti-cancer agents in Medicinal Chemistry (formerly current Medicinal …, 2022 | 28 | 2022 |
| Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers K Venetis, E Sajjadi, S Haricharan, N Fusco Translational Cancer Research 9 (7), 4060, 2020 | 28 | 2020 |
| Low-risk triple-negative breast cancers: Clinico-pathological and molecular features N Fusco, E Sajjadi, K Venetis, M Ivanova, S Andaloro, E Guerini-Rocco, ... Critical Reviews in Oncology/Hematology 172, 103643, 2022 | 27 | 2022 |
| Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists N Fusco, M Ragazzi, E Sajjadi, K Venetis, R Piciotti, S Morganti, ... Histology and histopathology 36 (12), 1235-1245, 2021 | 27 | 2021 |
| Improving HER2 testing reproducibility in HER2-low breast cancer E Sajjadi, K Venetis, M Ivanova, N Fusco Cancer Drug Resistance 5 (4), 882, 2022 | 25 | 2022 |
| Bone muscle crosstalk in spinal cord injuries: Pathophysiology and implications for patients’ quality of life M Invernizzi, A de Sire, S Carda, K Venetis, F Renò, C Cisari, N Fusco Current osteoporosis reports 18, 422-431, 2020 | 23 | 2020 |
| Efficacy of antiresorptive drugs on bone mineral density in post-menopausal women with early breast cancer receiving adjuvant aromatase inhibitors: a systematic review of … A de Sire, L Lippi, K Venetis, S Morganti, E Sajjadi, C Curci, ... Frontiers in Oncology 11, 829875, 2022 | 22 | 2022 |
| Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: a multi-parametric analysis A Esposito, A Marra, V Bagnardi, S Frassoni, S Morganti, G Viale, ... European Journal of Cancer 145, 197-209, 2021 | 21 | 2021 |
